Hsbc Holdings PLC Mei Pharma, Inc. Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$2.73 - $4.5 $161,075 - $265,509	-59,002 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.6 - $3.32 $40,541 - $51,768	-15,593 Reduced 20.9%	59,002 $155,000
Q3 2020 Nov 12, 2020	SELL	$2.46 - $4.27 $53,017 - $92,027	-21,552 Reduced 22.42%	74,595 $235,000
Q2 2020 Aug 14, 2020	SELL	$1.45 - $4.3 $28,554 - $84,679	-19,693 Reduced 17.0%	96,147 $397,000
Q4 2019 Feb 14, 2020	SELL	$1.65 - $2.48 $191,136 - $287,283	-115,840 Reduced 50.0%	115,840 $287,000
Q3 2019 Nov 14, 2019	BUY	$1.48 - $2.52 $342,886 - $583,833	231,680 New	231,680 $389,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.